Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis.

van den Brand FF, van der Veen KS, de Boer YS, van Gerven NM, Lissenberg-Witte BI, Beuers U, van Erpecum KJ, van Buuren HR, den Ouden JW, Brouwer JT, Vrolijk JM, Verdonk RC, van Hoek B, Koek GH, Drenth JPH, Guichelaar MMJ, Mulder CJJ, Bloemena E, van Nieuwkerk CMJ, Bouma G; Dutch Autoimmune Hepatitis Study group.

Clin Gastroenterol Hepatol. 2018 Oct 3. pii: S1542-3565(18)31078-4. doi: 10.1016/j.cgh.2018.09.046. [Epub ahead of print]

PMID:
30291909
2.

Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining.

de Boer DV, Brink A, Buijze M, Stigter-van Walsum M, Hunter KD, Ylstra B, Bloemena E, Leemans CR, Brakenhoff RH.

Mol Cancer Res. 2018 Sep 17. doi: 10.1158/1541-7786.MCR-18-0445. [Epub ahead of print]

PMID:
30224542
3.

A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma.

Hussein AA, Forouzanfar T, Bloemena E, de Visscher J, Brakenhoff RH, Leemans CR, Helder MN.

Br J Cancer. 2018 Sep;119(6):724-736. doi: 10.1038/s41416-018-0233-4. Epub 2018 Aug 21.

PMID:
30131545
4.

Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands.

van den Brand FF, van Nieuwkerk CMJ, Verwer BJ, de Boer YS, de Boer NKH, Mulder CJJ, Bloemena E, Bakker CM, Vrolijk JM, Drenth JPH, Tan ACITL, Ter Borg F, Ter Borg MJ, van den Hazel SJ, Inderson A, Tushuizen ME, Bouma G.

Aliment Pharmacol Ther. 2018 Oct;48(7):761-767. doi: 10.1111/apt.14939. Epub 2018 Aug 15.

5.

Clear Cell Odontogenic Carcinoma: Occurrence of EWSR1-CREB1 as Alternative Fusion Gene to EWSR1-ATF1.

Vogels R, Baumhoer D, van Gorp J, Eijkelenboom A, Verdijk M, van Cleef P, Bloemena E, Slootweg PJ, Lohman B, Debiec-Rychter M, Flucke U.

Head Neck Pathol. 2018 Jul 25. doi: 10.1007/s12105-018-0953-z. [Epub ahead of print]

PMID:
30047065
6.

Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands.

Boon E, Valstar MH, van der Graaf WTA, Bloemena E, Willems SM, Meeuwis CA, Slootweg PJ, Smit LA, Merkx MAW, Takes RP, Kaanders JHAM, Groenen PJTA, Flucke UE, van Herpen CML.

Oral Oncol. 2018 Jul;82:29-33. doi: 10.1016/j.oraloncology.2018.04.022. Epub 2018 May 11.

7.

Resorption of the mandibular residual ridge: A micro-CT and histomorphometrical analysis.

Dekker H, Schulten EAJM, Ten Bruggenkate CM, Bloemena E, van Ruijven L, Bravenboer N.

Gerodontology. 2018 May 21. doi: 10.1111/ger.12343. [Epub ahead of print]

PMID:
29781536
8.

Genetic profiling of poorly differentiated sinonasal tumours.

López-Hernández A, Vivanco B, Franchi A, Bloemena E, Cabal VN, Potes S, Riobello C, García-Inclán C, López F, Llorente JL, Hermsen M.

Sci Rep. 2018 Mar 5;8(1):3998. doi: 10.1038/s41598-018-21690-6.

9.

A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.

Boon E, Bel M, van Boxtel W, van der Graaf WTA, van Es RJJ, Eerenstein SEJ, Baatenburg de Jong RJ, van den Brekel MWM, van der Velden LA, Witjes MJH, Hoeben A, Willems SM, Bloemena E, Smit LA, Oosting SF; PALGA Group, Jonker MA, Flucke UE, van Herpen CML.

Int J Cancer. 2018 Aug 15;143(4):758-766. doi: 10.1002/ijc.31353. Epub 2018 Mar 23.

10.

Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions.

Rietbergen MM, van Bokhoven AAJD, Lissenberg-Witte BI, Heideman DAM, Leemans CR, Brakenhoff RH, Bloemena E.

Int J Cancer. 2018 Jul 15;143(2):283-288. doi: 10.1002/ijc.31315. Epub 2018 Mar 2.

PMID:
29441569
11.

Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.

Nauta IH, Rietbergen MM, van Bokhoven AAJD, Bloemena E, Lissenberg-Witte BI, Heideman DAM, Baatenburg de Jong RJ, Brakenhoff RH, Leemans CR.

Ann Oncol. 2018 May 1;29(5):1273-1279. doi: 10.1093/annonc/mdy060.

PMID:
29438466
12.

Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck.

de Boer DV, Martens-de Kemp SR, Buijze M, Stigter-van Walsum M, Bloemena E, Dietrich R, Leemans CR, van Beusechem VW, Braakhuis BJM, Brakenhoff RH.

Oncotarget. 2017 May 16;8(58):97928-97940. doi: 10.18632/oncotarget.17880. eCollection 2017 Nov 17.

13.

Evaluation of vascular features of vocal cords proposed by the European Laryngological Society.

Šifrer R, Rijken JA, Leemans CR, Eerenstein SEJ, van Weert S, Hendrickx JJ, Bloemena E, Heuveling DA, Rinkel RNPM.

Eur Arch Otorhinolaryngol. 2018 Jan;275(1):147-151. doi: 10.1007/s00405-017-4791-5. Epub 2017 Oct 30.

14.

High number of chromosomal copy number aberrations inversely relates to t(11;19)(q21;p13) translocation status in mucoepidermoid carcinoma of the salivary glands.

Matse JH, Veerman ECI, Bolscher JGM, Leemans CR, Ylstra B, Bloemena E.

Oncotarget. 2017 Apr 20;8(41):69456-69464. doi: 10.18632/oncotarget.17282. eCollection 2017 Sep 19.

15.

Prognostic modeling of oral cancer by gene profiles and clinicopathological co-variables.

Mes SW, Te Beest D, Poli T, Rossi S, Scheckenbach K, van Wieringen WN, Brink A, Bertani N, Lanfranco D, Silini EM, van Diest PJ, Bloemena E, Leemans CR, van de Wiel MA, Brakenhoff RH.

Oncotarget. 2017 Jul 26;8(35):59312-59323. doi: 10.18632/oncotarget.19576. eCollection 2017 Aug 29.

16.

Radiation-induced changes in the microstructure of epithelial cells of the oral mucosa: A comparative light and electron microscopic study.

Asikainen PJ, Dekker H, Sirviö E, Mikkonen J, Schulten EAJM, Bloemena E, Koistinen A, Ten Bruggenkate CM, Kullaa AM.

J Oral Pathol Med. 2017 Nov;46(10):1004-1010. doi: 10.1111/jop.12639. Epub 2017 Sep 15.

PMID:
28865083
17.

Mucoepidermoid carcinoma-associated expression of MUC5AC, MUC5B and mucin-type carbohydrate antigen sialyl-Tn in the parotid gland.

Matse JH, Bharos WK, Veerman ECI, Bloemena E, Bolscher JGM.

Arch Oral Biol. 2017 Oct;82:121-126. doi: 10.1016/j.archoralbio.2017.06.010. Epub 2017 Jun 13.

PMID:
28628803
18.

Smoking is associated with severity of liver fibrosis but not with histological severity in nonalcoholic fatty liver disease. Results from a cross-sectional study.

Munsterman ID, Smits MM, Andriessen R, van Nieuwkerk CMJ, Bloemena E, Mulder CJJ, Tjwa ETTL, van Geenen EJM.

Scand J Gastroenterol. 2017 Aug;52(8):881-885. doi: 10.1080/00365521.2017.1315169. Epub 2017 Apr 27.

PMID:
28446050
19.

Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy.

Seinen ML, van Asseldonk DP, de Boer NK, Bouma G, van Nieuwkerk CM, Mulder CJ, Bloemena E, van Bodegraven AA.

Inflamm Bowel Dis. 2017 Mar;23(3):448-452. doi: 10.1097/MIB.0000000000001036.

PMID:
28151736
20.

The added value of SPECT-CT for the identification of sentinel lymph nodes in early stage oral cancer.

den Toom IJ, van Schie A, van Weert S, Karagozoglu KH, Bloemena E, Hoekstra OS, de Bree R.

Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):998-1004. doi: 10.1007/s00259-017-3613-8. Epub 2017 Jan 29.

21.

Immunoglobulin G4-mediated sclerosing cholangitis as a risk factor for cholangiocarcinoma: A case report.

Koopman KE, Bloemena E, Kazemier G, Klemt-Kropp M.

Mol Clin Oncol. 2016 Dec;5(6):786-788. doi: 10.3892/mco.2016.1040. Epub 2016 Sep 30.

22.

Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment.

Kuiper JL, Hashemi SM, Thunnissen E, Snijders PJ, Grünberg K, Bloemena E, Sie D, Postmus PE, Heideman DA, Smit EF.

Br J Cancer. 2016 Dec 6;115(12):1504-1512. doi: 10.1038/bjc.2016.372. Epub 2016 Nov 22.

23.

Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck.

van Weert S, Reinhard R, Bloemena E, Buter J, Witte BI, Vergeer MR, Leemans CR.

Head Neck. 2017 Mar;39(3):456-463. doi: 10.1002/hed.24613. Epub 2016 Oct 24.

PMID:
27775851
24.

Additional non-sentinel lymph node metastases in early oral cancer patients with positive sentinel lymph nodes.

Den Toom IJ, Bloemena E, van Weert S, Karagozoglu KH, Hoekstra OS, de Bree R.

Eur Arch Otorhinolaryngol. 2017 Feb;274(2):961-968. doi: 10.1007/s00405-016-4280-2. Epub 2016 Aug 25.

25.

The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease.

van Asseldonk DP, Jharap B, Verheij J, den Hartog G, Westerveld DB, Becx MC, Russel MG, Engels LG, de Jong DJ, Witte BI, Mulder CJ, van Nieuwkerk CM, Bloemena E, de Boer NK, van Bodegraven AA.

Inflamm Bowel Dis. 2016 Sep;22(9):2112-20. doi: 10.1097/MIB.0000000000000869.

PMID:
27482972
26.

Sentinel Node in Oral Cancer: The Nuclear Medicine Aspects. A Survey from the Sentinel European Node Trial.

Tartaglione G, Stoeckli SJ, de Bree R, Schilling C, Flach GB, Bakholdt V, Sorensen JA, Bilde A, von Buchwald C, Lawson G, Dequanter D, Villarreal PM, Forcelledo MF, Amezaga JA, Moreira A, Poli T, Grandi C, Vigili MG, O'Doherty M, Donner D, Bloemena E, Rahimi S, Gurney B, Haerle SK, Broglie MA, Huber GF, Krogdah AL, Sebbesen LR, Odell E, Junquera Gutierrez LM, Barbier L, Santamaria-Zuazua J, Jacome M, Nollevaux MC, Bragantini E, Lothaire P, Silini EM, Sesenna E, Dolivet G, Mastronicola R, Leroux A, Sassoon I, Sloan P, Colletti PM, Rubello D, McGurk M.

Clin Nucl Med. 2016 Jul;41(7):534-42. doi: 10.1097/RLU.0000000000001241.

27.

A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency.

Punt S, Dronkers EA, Welters MJ, Goedemans R, Koljenović S, Bloemena E, Snijders PJ, Gorter A, van der Burg SH, Baatenburg de Jong RJ, Jordanova ES.

Cancer Immunol Immunother. 2016 Apr;65(4):393-403. doi: 10.1007/s00262-016-1805-x. Epub 2016 Feb 22.

28.

Correction: Human Salivary Micro-RNA in Patients with Parotid Salivary Gland Neoplasms.

Matse JH, Yoshizawa J, Wang X, Elashoff D, Bolscher JG, Veerman EC, Leemans CR, Pegtel DM, Wong DT, Bloemena E.

PLoS One. 2016 Jan 5;11(1):e0146701. doi: 10.1371/journal.pone.0146701. eCollection 2016.

29.

Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer.

Schilling C, Stoeckli SJ, Haerle SK, Broglie MA, Huber GF, Sorensen JA, Bakholdt V, Krogdahl A, von Buchwald C, Bilde A, Sebbesen LR, Odell E, Gurney B, O'Doherty M, de Bree R, Bloemena E, Flach GB, Villarreal PM, Fresno Forcelledo MF, Junquera Gutiérrez LM, Amézaga JA, Barbier L, Santamaría-Zuazua J, Moreira A, Jacome M, Vigili MG, Rahimi S, Tartaglione G, Lawson G, Nollevaux MC, Grandi C, Donner D, Bragantini E, Dequanter D, Lothaire P, Poli T, Silini EM, Sesenna E, Dolivet G, Mastronicola R, Leroux A, Sassoon I, Sloan P, McGurk M.

Eur J Cancer. 2015 Dec;51(18):2777-84. doi: 10.1016/j.ejca.2015.08.023. Epub 2015 Nov 18.

PMID:
26597442
30.

Human Salivary Micro-RNA in Patients with Parotid Salivary Gland Neoplasms.

Matse JH, Yoshizawa J, Wang X, Elashoff D, Bolscher JG, Veerman EC, Leemans CR, Pegtel DM, Wong DT, Bloemena E.

PLoS One. 2015 Nov 6;10(11):e0142264. doi: 10.1371/journal.pone.0142264. eCollection 2015. Erratum in: PLoS One. 2016;11(1):e0146701. Pegtel, Michiel D [corrected to Pegtel, D Michiel].

31.

Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement.

Jharap B, van Asseldonk DP, de Boer NK, Bedossa P, Diebold J, Jonker AM, Leteurtre E, Verheij J, Wendum D, Wrba F, Zondervan PE, Colombel JF, Reinisch W, Mulder CJ, Bloemena E, van Bodegraven AA; NRH-Pathology Investigators.

PLoS One. 2015 Jun 8;10(6):e0120299. doi: 10.1371/journal.pone.0120299. eCollection 2015.

32.

Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe.

Rietbergen MM, Witte BI, Velazquez ER, Snijders PJ, Bloemena E, Speel EJ, Brakenhoff RH, Kremer B, Lambin P, Leemans CR.

Br J Cancer. 2015 May 26;112(11):1733-6. doi: 10.1038/bjc.2015.139. Epub 2015 May 7.

33.

Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.

Schouten CS, de Graaf P, Alberts FM, Hoekstra OS, Comans EF, Bloemena E, Witte BI, Sanchez E, Leemans CR, Castelijns JA, de Bree R.

Oral Oncol. 2015 May;51(5):541-7. doi: 10.1016/j.oraloncology.2015.01.017. Epub 2015 Feb 26.

PMID:
25725587
34.

Quantitative diffusion-weighted MRI parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.

Schouten CS, de Graaf P, Bloemena E, Witte BI, Braakhuis BJ, Brakenhoff RH, Leemans CR, Castelijns JA, de Bree R.

AJNR Am J Neuroradiol. 2015 Apr;36(4):763-7. doi: 10.3174/ajnr.A4271. Epub 2015 Feb 26.

35.

HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1.

van Gerven NM, de Boer YS, Zwiers A, Verwer BJ, Drenth JP, van Hoek B, van Erpecum KJ, Beuers U, van Buuren HR, den Ouden JW, Verdonk RC, Koek GH, Brouwer JT, Guichelaar MM, Vrolijk JM, Coenraad MJ, Kraal G, Mulder CJ, van Nieuwkerk CM, Bloemena E, Verspaget HW, Kumar V, Zhernakova A, Wijmenga C, Franke L, Bouma G; Dutch Autoimmune Hepatitis Study Group.

Genes Immun. 2015 Jun;16(4):247-52. doi: 10.1038/gene.2014.82. Epub 2015 Jan 22.

PMID:
25611558
36.

Histopathological grading of adenoid cystic carcinoma of the head and neck: analysis of currently used grading systems and proposal for a simplified grading scheme.

van Weert S, van der Waal I, Witte BI, Leemans CR, Bloemena E.

Oral Oncol. 2015 Jan;51(1):71-6. doi: 10.1016/j.oraloncology.2014.10.007. Epub 2014 Oct 28.

37.

Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.

Schouten CS, Hakim S, Boellaard R, Bloemena E, Doornaert PA, Witte BI, Braakhuis BJ, Brakenhoff RH, Leemans CR, Hoekstra OS, de Bree R.

Head Neck. 2016 Apr;38(4):529-35. doi: 10.1002/hed.23920. Epub 2015 May 26.

PMID:
25352335
38.

Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapy.

Eskens FA, van Erpecum KJ, de Jong KP, van Delden OM, Klumpen HJ, Verhoef C, Jansen PL, van den Bosch MA, Méndez Romero A, Verheij J, Bloemena E, de Man RA.

Neth J Med. 2014 Jul;72(6):299-304. Review.

39.

Assessment of the histopathological key features in autoimmune hepatitis.

de Boer YS, van Nieuwkerk CM, Witte BI, Mulder CJ, Bouma G, Bloemena E.

Histopathology. 2015 Feb;66(3):351-62. doi: 10.1111/his.12558. Epub 2014 Dec 22.

PMID:
25257662
40.

Sentinel lymph node biopsy in clinically N0 T1-T2 staged oral cancer: the Dutch multicenter trial.

Flach GB, Bloemena E, Klop WM, van Es RJ, Schepman KP, Hoekstra OS, Castelijns JA, Leemans CR, de Bree R.

Oral Oncol. 2014 Oct;50(10):1020-4. doi: 10.1016/j.oraloncology.2014.07.020. Epub 2014 Aug 19.

PMID:
25164950
41.

The role of a labial salivary gland biopsy in the diagnostic procedure for Sjögren's syndrome; a study of 94 cases.

van Stein-Callenfels D, Tan J, Bloemena E, van Vugt RM, Voskuyl AE, Santana NT, van der Waal I.

Med Oral Patol Oral Cir Bucal. 2014 Jul 1;19(4):e372-6.

42.

Genome-wide association study identifies variants associated with autoimmune hepatitis type 1.

de Boer YS, van Gerven NM, Zwiers A, Verwer BJ, van Hoek B, van Erpecum KJ, Beuers U, van Buuren HR, Drenth JP, den Ouden JW, Verdonk RC, Koek GH, Brouwer JT, Guichelaar MM, Vrolijk JM, Kraal G, Mulder CJ, van Nieuwkerk CM, Fischer J, Berg T, Stickel F, Sarrazin C, Schramm C, Lohse AW, Weiler-Normann C, Lerch MM, Nauck M, Völzke H, Homuth G, Bloemena E, Verspaget HW, Kumar V, Zhernakova A, Wijmenga C, Franke L, Bouma G; Dutch Autoimmune Hepatitis Study Group; LifeLines Cohort Study; Study of Health in Pomerania.

Gastroenterology. 2014 Aug;147(2):443-52.e5. doi: 10.1053/j.gastro.2014.04.022. Epub 2014 Apr 23.

PMID:
24768677
43.

Sentinel node biopsy for early-stage oral cavity cancer: the VU University Medical Center experience.

Den Toom IJ, Heuveling DA, Flach GB, van Weert S, Karagozoglu KH, van Schie A, Bloemena E, Leemans CR, de Bree R.

Head Neck. 2015 Apr;37(4):573-8. doi: 10.1002/hed.23632. Epub 2014 May 27.

PMID:
24677355
44.

Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer.

Rietbergen MM, Martens-de Kemp SR, Bloemena E, Witte BI, Brink A, Baatenburg de Jong RJ, Leemans CR, Braakhuis BJ, Brakenhoff RH.

Eur J Cancer. 2014 Mar;50(4):765-73. doi: 10.1016/j.ejca.2013.11.010. Epub 2013 Dec 4.

45.

Schneiderian papilloma of the temporal bone.

van der Putten L, Bloemena E, Merkus P, Hensen EF.

BMJ Case Rep. 2013 Dec 5;2013. pii: bcr2013201219. doi: 10.1136/bcr-2013-201219.

46.

Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.

Rietbergen MM, Snijders PJ, Beekzada D, Braakhuis BJ, Brink A, Heideman DA, Hesselink AT, Witte BI, Bloemena E, Baatenburg-De Jong RJ, Leemans CR, Brakenhoff RH.

Int J Cancer. 2014 May 15;134(10):2366-72. doi: 10.1002/ijc.28580. Epub 2013 Nov 19.

47.

Molecular screening of oral precancer.

Graveland AP, Bremmer JF, de Maaker M, Brink A, Cobussen P, Zwart M, Braakhuis BJ, Bloemena E, van der Waal I, Leemans CR, Brakenhoff RH.

Oral Oncol. 2013 Dec;49(12):1129-35. doi: 10.1016/j.oraloncology.2013.09.005. Epub 2013 Oct 9.

PMID:
24120275
48.

No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors.

Rietbergen MM, Braakhuis BJ, Moukhtari N, Bloemena E, Brink A, Sie D, Ylstra B, Baatenburg de Jong RJ, Snijders PJ, Brakenhoff RH, Leemans CR.

J Oral Pathol Med. 2014 Feb;43(2):137-42. doi: 10.1111/jop.12123. Epub 2013 Oct 11.

PMID:
24118314
49.

TP53 mutation and human papilloma virus status of oral squamous cell carcinomas in young adult patients.

Braakhuis BJ, Rietbergen MM, Buijze M, Snijders PJ, Bloemena E, Brakenhoff RH, Leemans CR.

Oral Dis. 2014 Sep;20(6):602-8. doi: 10.1111/odi.12178. Epub 2013 Sep 23.

PMID:
24112103
50.

Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials.

Rietbergen MM, Brakenhoff RH, Bloemena E, Witte BI, Snijders PJ, Heideman DA, Boon D, Koljenovic S, Baatenburg-de Jong RJ, Leemans CR.

Ann Oncol. 2013 Nov;24(11):2740-5. doi: 10.1093/annonc/mdt319. Epub 2013 Aug 14.

PMID:
23946330

Supplemental Content

Loading ...
Support Center